Shravin Bharti Mittal, Social Capital, Golden Palm Investments, 4DX Ventures & Breyer Capital’s Series A investment into mPharma’s operations in Ghana for USD 6.6 million

Lead party: Shravin Bharti Mittal (lead investor/buyer)Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed). Target: mPharma Data, Inc. (private company) · Sector: Healthcare, Medical Supplies · Countries of operation: Zambia, Ghana, Malawi, Nigeria, Gabon, Uganda, Zimbabwe, Kenya, Ethiopia, Rwanda Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture…


Lead party: Shravin Bharti Mittal (lead investor/buyer)

Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).

Target: mPharma Data, Inc. (private company) · Sector: Healthcare, Medical Supplies · Countries of operation: Zambia, Ghana, Malawi, Nigeria, Gabon, Uganda, Zimbabwe, Kenya, Ethiopia, Rwanda

Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Series A · Deal amount: US$6.6m · Fund: 4DX Ventures Fund I

Lead investor/buyer: Shravin Bharti Mittal · Investors/buyers: Social Capital, Golden Palm Investments, 4DX Ventures Management LLC, Shravin Bharti Mittal, Breyer Capital

Legal advisers: not identified in the source record.

Source: announced 23 November 2017. Original announcement: medium.com.